Abstract CT272: Clinical trial in progress: BCC022 a phase II trial of tipifarnib and naxitamab for relapsed/refractory neuroblastoma
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Saint Louis University, Medical University of South Carolina
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154702645
Cites:
Cited by:
Related to:
